I will be very brief, Madam Chair.
I would like to come back to a drug, the Gardasil vaccine, which was linked to the death of young girls in other countries. There were apparently 11 deaths. When a drug is taken off the market, under what circumstances—and I know that you are a legal professional and that you provide help in similar cases—there be agreement to continue the vaccination campaign? We know that Quebec has started an intensive campaign to vaccinate adolescent girls, even though some people have died elsewhere. What is the relationship between the drug and the cause of the illness?